Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeBlog › Enhance MD Review 2026

Journal · Updated 2026-08-11

Enhance MD Review 2026: Bundled Metabolic Programs From $212, Priced as Programs

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

Short answer — August 2026

Enhance MD's figures are program prices, first-party verified July 2026: "GLP-1 Core" (semaglutide) at two twelve a month with a one twelve first month; tirzepatide "Advanced" at two eighty; the "Elite" combo at three twenty-two; microdosed tirzepatide at one sixty-nine — each bundling four weeks of medication, ongoing provider care, and metabolic lab testing every six months. Read as medication prices they look expensive; read as they're sold — a metabolic program with medication inside — they compare to Mochi's two seventy-eight, not to Henry's one seventy-nine. Our tables carry both readings: the all-in figures ranked, the bundle contents labeled, and the microdosing tier flagged with the standing evidence caveat.

Pricing the bundle honestly

The comparison set is the membership tier: against Mochi (two seventy-eight tirzepatide, dietitian-heavy, ~ten states), Enhance's two eighty ties on price with a different bundle (labs every six months vs programming depth — ask which you'd use); against Ivim's two seventy-eight, similar math. Against the medication-only tier, the premiums are the product: one-oh-one monthly over Henry on tirzepatide, eighty-three over bmiMD on semaglutide — fair if the provider-care-plus-labs layer is real and used, per the clinic-premium test, and a rounding error if not. The one sixty-nine micro-tirzepatide tier deserves its own sentence: it undercuts the program's standard tirzepatide by one eleven for a sub-maintenance dose no trial validates — the clearest priced illustration of the microdosing trade in our records. First-month discounts (one twelve on Core) are labeled intro pricing; budget on month two's number.

Verdict

Enhance MD is the labs-forward entry in the managed tier — a defensible buy for someone who wants semiannual metabolic panels and standing provider care bundled, priced level with its true peers. It is not a medication-price contender at any tier, and its cheapest number is its least-evidenced product. The three intake items: exactly which labs and visit cadence the bundle includes, in writing; the pharmacy name; and, if microdosing tempts, the dose in milligrams and the escalation price — because one sixty-nine that becomes two eighty at the first plateau was never the cheap option.

Questions people ask

How much does Enhance MD cost?

Program tiers (first-party, July 2026): GLP-1 Core semaglutide $212/month ($112 first month); tirzepatide Advanced $280; Elite combo $322; microdosed tirzepatide $169. Each bundles medication, ongoing provider care, and metabolic labs every six months — program prices, not medication prices.

Is Enhance MD worth it vs Henry Meds or bmiMD?

Different products: Henry/bmiMD sell medication-inclusive simplicity at $129–$179; Enhance sells a metabolic program at $212–$322. The $83–$101 monthly premium buys labs-every-six-months plus provider care — worth it if you'd otherwise pay for those, not if you just need the vial. Its true peers are Mochi ($278) and Ivim ($278).

What's the catch with Enhance's $169 microdosed tirzepatide?

It's a sub-maintenance dose at a discount — $111 under the program's standard tirzepatide — with no trial supporting equivalent results at lower doses (the evidence points the other way). Legitimate for prescriber-directed tolerability or maintenance; a false economy for full-result shoppers. Get the dose in mg and the escalation price in writing.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.